Cladribine in Multiple Sclerosis: Real-World experience focused on efficacy and safety from Colombia, Latin America

被引：0
|
作者：
Garcia Bonnito, Juan Raul [1 ]
机构：
[1] Marly Clin, Bogota, Colombia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1579/1576
引用
收藏
页码：1007 / 1007
页数：1
相关论文
共 50 条
  • [1] Real-world experience of ocrelizumab in multiple sclerosis patients in latin america
    Rojas, J.
    Patrucco, L.
    Fruns, M.
    Flores-Rivera, J.
    Carnero Contentti, E.
    Galleguillos, L.
    Alonso, R.
    Cristiano, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 548 - 548
  • [2] Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Fruns, Manuel
    Hornung, Giesela
    Flores, Jose
    Carnero Contentti, Edgar
    Adrian Lopez, Pablo
    Pablo Pettinicchi, Juan
    Caride, Alejandro
    Galleguillos, Lorna
    Barahona, Jorge
    Diaz, Violeta
    Hernandez, Marianella
    Alonso, Ricardo
    Cristiano, Edgardo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (04) : 305 - 309
  • [3] Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
    Moser, Tobias
    Ziemssen, Tjalf
    Sellner, Johann
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2022, 172 (15-16) : 365 - 372
  • [4] Cladribine use in multiple sclerosis: a monocentric real-world experience
    Pilotto, Silvy
    Mellino, Paolo
    Carmagnini, Daniele
    Frau, Jessica
    Coghe, Giancarlo
    Cocco, Eleonora
    Lorefice, Lorena
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 639 - 640
  • [5] Safety and effectiveness of cladribine in multiple sclerosis - real-world clinical experience from seven centers in Portugal
    Sequeira, Joao
    Santos, Monica
    Santos, Mariana
    Guerreiro, Rui Pedro
    Paredes Abreu, Pedro Miguel
    Batista, Sonia
    Cerqueira, Joao
    Ladeira, Filipa
    Ferreira, Joao
    Leitao, Lia
    Alves, Janice
    Martins, Emanuel
    Sa, Maria Jose
    Correia Sa, Joao Carlos
    Capela, Carlos
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 999 - 1000
  • [6] Safety and Effectiveness of Cladribine in Multiple Sclerosis: Real-World Clinical Experience From 5 Tertiary Hospitals in Portugal
    Santos, Monica
    Sequeira, Joao
    Abreu, Pedro
    Guerreiro, Rui
    Santos, Mariana
    Ferreira, Joao
    Brum, Marisa
    Ladeira, Filipa
    Leitao, Lia
    Dias, Rafael
    Sa, Maria Jose
    Salgado, Vasco
    Capela, Carlos
    de Sa, Joao
    CLINICAL NEUROPHARMACOLOGY, 2023, 46 (03) : 105 - 111
  • [7] Real-World Efficacy and Safety of Oral Cladribine in Korean Patients with Relapsing-Remitting Multiple Sclerosis
    Kim, Su-Hyun
    Kim, Ho Jin
    Kim, Sung Min
    Shin, Ha Young
    Kwon, Young Nam
    Nam, Tai-Seung
    Kim, Byoung Joon
    Min, Ju-Hong
    Kim, Jun Soon
    Su, Park Min
    Kim, Nam-Hee
    Shin, Jin-Hong
    Park, Young Eun
    Lim, Young-Min
    Lee, Eun-Jae
    Kim, Woojun
    Shon, Eun Hee
    Lee, Tae-Kyeong
    Taha, Karim
    Seo, Beom-Jun
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1099 - 1099
  • [8] Safety and Efficacy of Cladribine in Multiple Sclerosis: A Descriptive Study of 151 Patients in a Real-World Setting.
    Bocero Garcia, Antonio
    Lopez Ruiz, Rocio
    Rincon Valencia, Alexandra
    Montero Ramirez, Emilio
    Torres Moral, Alejandro
    Garcia-Soto, Julio Dotor
    Ben-Yelun Insenser, Miriam
    Arzalluz Luque, Joaquin
    Eichau, Sara
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1073 - 1073
  • [9] A real-world single-centre analysis of the safety and efficacy of cladribine tablets for relapsing multiple sclerosis
    Aerts, S.
    Khan, H.
    Severijns, D.
    Popescu, V.
    Peeters, L. M.
    Van Wijmeersch, B.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 892 - 892
  • [10] REAL WORLD DATA EVALUATING EFFICACY AND SAFETY OF ORAL CLADRIBINE FOR MULTIPLE SCLEROSIS
    Nasir, Moneeb
    Rabvukwa, Plaxedes
    Fuller, Sarah
    Chaudhuri, Abhijit
    Mattoscio, Miriam
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
12345